Screener
MoonLake Immunotherapeutics MLTX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 8:55 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001821586-26-000007
| (in thousands, except share and per share data) | March 31, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 532 | 577 |
| Other non-current assets | 1,344 | 596 |
| Total non-current assets | 3,733 | 2,739 |
| Total assets | $400,374 | $424,433 |
| Liabilities and Equity | ||
| Current liabilities | ||
| Trade and other payables | $23,380 | $29,553 |
| Accrued expenses and other current liabilities | 21,814 | 14,691 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is MoonLake Immunotherapeutics's total assets?
- MoonLake Immunotherapeutics (MLTX) reported total assets of $400.37M in Q1 2026.
- How has MoonLake Immunotherapeutics's total assets changed year-over-year?
- MoonLake Immunotherapeutics's total assets decreased by 21.7% year-over-year, from $511.26M to $400.37M.
- What is the long-term trend for MoonLake Immunotherapeutics's total assets?
- Over 5 years (2020 to 2025), MoonLake Immunotherapeutics's total assets has grown at a 29.5% compound annual growth rate (CAGR), from $116.63M to $424.43M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about MoonLake Immunotherapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude